Minimal Clinically Important Differences for Patient-Reported Outcome Measures of Fatigue in Patients With COPD Following Pulmonary Rehabilitation

Chest

Volumn 158, Issue 2, 2020, Pages 550-561

  Rebelo, Patrícia ^a   Oliveira, Ana ^a,b,c   Andrade, Lília ^d   Valente, Carla ^d   Marques, Alda ^a  

^a UNIVERSITY OF AVEIRO   (Portugal)

^b WEST PARK HEALTHCARE CENTRE   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d Centro Hospitalar do Baixo Vouga   (Portugal)

Author keywords

clinical decision making; exercise; health status; interpretability; outcome measurement

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; EXPECTORANT AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; MUSCARINIC RECEPTOR BLOCKING AGENT; SHORT ACTING DRUG; XANTHINE DERIVATIVE;

AGED; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE EXACERBATION; FATIGUE; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY FATIGUE SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMAL CLINICALLY IMPORTANT DIFFERENCE; MINIMUM DETECTABLE CHANGE; OBSERVATIONAL STUDY; PATIENT-REPORTED OUTCOME; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY REHABILITATION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ST. GEORGE RESPIRATORY QUESTIONNAIRE; COMPLICATION; MIDDLE AGED; PREDICTIVE VALUE; QUESTIONNAIRE; SYMPTOM ASSESSMENT;

AGED; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; MINIMAL CLINICALLY IMPORTANT DIFFERENCE; PATIENT REPORTED OUTCOME MEASURES; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SURVEYS AND QUESTIONNAIRES; SYMPTOM ASSESSMENT;

EID: 85082815844     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2020.02.045     Document Type: Conference Paper

References (71)

1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2019 Report). 2019. https://goldcopd.org/.
2. Peters, J.B., Heijdra, Y.F., Daudey, L., et al. Course of normal and abnormal fatigue in patients with chronic obstructive pulmonary disease, and its relationship with domains of health status. Patient Educ Counsel 85:2 (2011), 281–285.
3. Spruit, M.A., Vercoulen, J.H., Sprangers, M.A., Wouters, E.F., Fatigue in COPD: an important yet ignored symptom. Lancet Respir Med 5:7 (2017), 542–544.
4. Vercoulen, J.H., Swanink, C.M., Fennis, J.F., Galama, J.M., van der Meer, J.W., Bleijenberg, G., Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 38:5 (1994), 383–392.
5. Gruet, M., Fatigue in chronic respiratory diseases: theoretical framework and implications for real-life performance and rehabilitation. Frontiers Physiol, 9, 2018.
6. Ream, E., Richardson, A., Fatigue in patients with cancer and chronic obstructive airways disease: a phenomenological enquiry. Int J Nursing Studies 34:1 (1997), 44–53.
7. Beurskens, A.J., Bültmann, U., Kant, I., Vercoulen, J.H., Bleijenberg, G., Swaen, G.M., Fatigue among working people: validity of a questionnaire measure. Occup Environ Med 57:5 (2000), 353–357.
8. Kouijzer, M., Brusse-Keizer, M., Bode, C., COPD-related fatigue: Impact on daily life and treatment opportunities from the patient's perspective. Respir Med 141 (2018), 47–51.
9. Small, S., Lamb, M., Fatigue in chronic illness: the experience of individuals with chronic obstructive pulmonary disease and with asthma. J Adv Nurs 30:2 (1999), 469–478.
10. Stridsman, C., Skär, L., Hedman, L., Rönmark, E., Lindberg, A., Fatigue affects health status and predicts mortality among subjects with COPD: report from the population-based OLIN COPD study. COPD 12:2 (2015), 199–206.
11. Baghai-Ravary, R., Quint, J.K., Goldring, J.J., Hurst, J.R., Donaldson, G.C., Wedzicha, J.A., Determinants and impact of fatigue in patients with chronic obstructive pulmonary disease. Respir Med 103:2 (2009), 216–223.
12. Antoniu, S.A., Ungureanu, D., Measuring fatigue as a symptom in COPD: from descriptors and questionnaires to the importance of the problem. Chronic Respir Dis 12:3 (2015), 179–188.
13. Paddison, J.S., Effing, T.W., Quinn, S., Frith, P.A., Fatigue in COPD: association with functional status and hospitalisations. J Clin Epidemiol 41:3 (2013), 565–570.
14. McCarthy, B., Casey, D., Devane, D., Murphy, K., Murphy, E., Lacasse, Y., Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 23(2), 2015, CD003793.
15. Spruit, M.A., Singh, S.J., Garvey, C., et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 188:8 (2013), e13–e64.
16. Payne, C., Wiffen, P.J., Martin, S., Interventions for fatigue and weight loss in adults with advanced progressive illness. Cochrane Database of Syst Rev, 1, 2012, CD008427.
17. Lewko, A., Bidgood, P.L., Jewell, A., Garrod, R., Evaluation of multidimensional COPD-related subjective fatigue following a pulmonary rehabilitation programme. Respir Med 108:1 (2014), 95–102.
18. Van Herck, M., Antons, J., Vercoulen, J.H., et al. Pulmonary rehabilitation reduces subjective fatigue in COPD: a responder analysis. J Clin Med, 8(8), 2019, 1264.
19. Johnston, B.C., Ebrahim, S., Carrasco-Labra, A., et al. Minimally important difference estimates and methods: a protocol. BMJ Open, 5(10), 2015, e007953.
20. Cook, C.E., Clinimetrics corner: the minimal clinically important change score (MCID): a necessary pretense. J Man Manip Ther 16:4 (2008), 82E–83E.
21. Guyatt, G.H., Osoba, D., Wu, A.W., Wyrwich, K.W., Norman, G.R., Clinical Significance Consensus Meeting Group. Methods to explain the clinical significance of health status measures. Mayo Clinic Proceed 77:4 (2002), 371–383.
22. Jaeschke, R., Singer, J., Guyatt, G.H., Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials 10:4 (1989), 407–415.
23. Wright, A., Hannon, J., Hegedus, E.J., Kavchak, A.E., Clinimetrics corner: a closer look at the minimal clinically important difference (MCID). J Man Manip Ther 20:3 (2012), 160–166.
24. Angst, F., Aeschlimann, A., Angst, J., The minimal clinically important difference raised the significance of outcome effects above the statistical level, with methodological implications for future studies. J Clin Epidemiol 82 (2017), 128–136.
25. Jones, P., Interpreting thresholds for a clinically significant change in health status in asthma and COPD. J Clin Epidemiol 19:3 (2002), 398–404.
26. Copay, A.G., Subach, B.R., Glassman, S.D., Polly, D.W., Schuler, T.C., Understanding the minimum clinically important difference: a review of concepts and methods. Spine J 7:5 (2007), 541–546.
27. Revicki, D., Hays, R.D., Cella, D., Sloan, J., Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 61:2 (2008), 102–109.
28. Rai, S.K., Yazdany, J., Fortin, P.R., Aviña-Zubieta, J.A., Approaches for estimating minimal clinically important differences in systemic lupus erythematosus. Arthritis Res Ther, 17(1), 2015, 143.
29. Haley, S.M., Fragala-Pinkham, M.A., Interpreting change scores of tests and measures used in physical therapy. Phys Ther 86:5 (2006), 735–743.
30. Norman, G.R., Sloan, J.A., Wyrwich, K.W., Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Medical Care 41:5 (2003), 582–592.
31. Webster, K., Cella, D., Yost, K., The F unctional A ssessment of C hronic I llness T herapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes, 1(1), 2003, 79.
32. Al-Shair, K., Muellerova, H., Yorke, J., et al. Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale. Health and quality of life outcomes, 10(1), 2012, 100.
33. National Institutes of Health Clinical Center. NCT03799666. (Re)Vitalizing Pulmonary Rehabilitation for Patients with Chronic Respiratory Diseases (3R). ClinicalTrials.gov. Bethesda, MD: National Institutes of Health; 2019. https://clinicaltrials.gov/ct2/show/NCT03799666. Updated March 22, 2019.
34. Marques, A., Jácome, C., Rebelo, P., et al. Improving access to community-based pulmonary rehabilitation: 3R protocol for real-world settings with cost-benefit analysis. BMC Public Health, 19(676), 2019.
35. Laboratório de Investigação e Reabilitação Respiratória (Lab3R). Plataforma de Reabilitação Respiratória em Rede. 2018. http://3r.web.ua.pt/ Accessed December 20, 2019.
36. Terwee, C.B., Bot, S.D., de Boer, M.R., et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60:1 (2007), 34–42.
37. Mokkink LB, Prinsen CA, Patrick DL, et al. COSMIN study design checklist for patient-reported outcome measurement instruments. 2019.
38. Fischer, M.J., Scharloo, M., Abbink, J.J., et al. Drop-out and attendance in pulmonary rehabilitation: the role of clinical and psychosocial variables. Respir Med 103:10 (2009), 1564–1571.
39. Keating, A., Lee, A., Holland, A.E., What prevents people with chronic obstructive pulmonary disease from attending pulmonary rehabilitation? A systematic review. Chronic Respir Dis 8:2 (2011), 89–99.
40. Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:5 (1987), 373–383.
41. Jones, P., Harding, G., Berry, P., Wiklund, I., Chen, W., Leidy, N.K., Development and first validation of the COPD Assessment Test. J Clin Epidemiol 34:3 (2009), 648–654.
42. Jones, P.W., Quirk, F.H., Baveystock, C.M., Littlejohns, P., A self-complete measure of health status for chronic airflow limitation. Am Rev Respir Dis 145:6 (1992), 1321–1327.
43. Elbers, R.G., Rietberg, M.B., van Wegen, E.E., et al. Self-report fatigue questionnaires in multiple sclerosis, Parkinson's disease and stroke: a systematic review of measurement properties. Quality Life Res 21:6 (2012), 925–944.
44. Cella, D., Lai, J.S., Chang, C.H., Peterman, A., Slavin, M., Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 94:2 (2002), 528–538.
45. Anderson, W.H., Ha, J.W., Couper, D.J., et al. Variability in objective and subjective measures affects baseline values in studies of patients with COPD. PloS One, 12(9), 2017, e0184606.
46. Al-Shair, K., Müllerova, H., Locantore, N., et al. Fatigue components in COPD patients and controls using the FACIT-F scale; data from ECLIPSE study. J Clin Epidemiol, 38, 2011, 3624.
47. Worm-Smeitink, M., Gielissen, M., Bloot, L., et al. The assessment of fatigue: psychometric qualities and norms for the Checklist Individual Strength. J Psychosomat Res 98 (2017), 40–46.
48. van Koulil, S., Kraaimaat, F.W., van Lankveld, W., van Riel, P.L., Evers, A.W., A patient's perspective on multidisciplinary treatment gain for fibromyalgia: an indicator for pre-post treatment effects?. Arthritis Care Res 61:12 (2009), 1626–1632.
49. Panitz, S., Kornhuber, M., Hanisch, F., The Checklist Individual Strength (CIS20-R) in patients with amyotrophic lateral sclerosis—a longitudinal study. Acta Neurol Scand 131:6 (2015), 372–380.
50. Evers, A.W., Kraaimaat, F.W., van Riel, P.L., de Jong, A.J., Tailored cognitive-behavioral therapy in early rheumatoid arthritis for patients at risk: a randomized controlled trial. Pain 100:1-2 (2002), 141–153.
51. Kamper, S.J., Maher, C.G., Mackay, G., Global rating of change scales: a review of strengths and weaknesses and considerations for design. J Man Manip Ther 17:3 (2009), 163–170.
52. McHorney, C.A., Tarlov, A.R., Individual-patient monitoring in clinical practice: are available health status surveys adequate?. Quality Life Res 4:4 (1995), 293–307.
53. Aggarwal, R., Ranganathan, P., Common pitfalls in statistical analysis: the use of correlation techniques. Perspect Clin Res, 7(4), 2016, 187.
54. Kon, S.S., Canavan, J.L., Jones, S.E., et al. Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir Med 2:3 (2014), 195–203.
55. Jones, P.W., St. George's respiratory questionnaire: MCID. COPD 2:1 (2005), 75–79.
56. McGee, S., Simplifying likelihood ratios. J Gen Intern Med 17:8 (2002), 647–650.
57. Alma, H., De Jong, C., Jelusic, D., et al. Health status instruments for patients with COPD in pulmonary rehabilitation: defining a minimal clinically important difference. NPJ Prim Care Respir Med, 26, 2016, 16041.
58. Cohen, J., A power primer. Psycholog Bull, 112(1), 1992, 155.
59. Oliveira, A., Machado, A., Marques, A., Minimal important and detectable differences of respiratory measures in outpatients with AECOPD. COPD 15:5 (2018), 479–488.
60. Alma, H., de Jong, C., Tsiligianni, I., Sanderman, R., Kocks, J., van der Molen, T., Clinically relevant differences in COPD health status: systematic review and triangulation. Eur Respir J, 52(3), 2018, 1800412.
61. Stridsman, C., Müllerova, H., Skär, L., Lindberg, A., Fatigue in COPD and the impact of respiratory symptoms and heart disease—a population-based study. COPD 10:2 (2013), 125–132.
62. Cella, D., Yount, S., Sorensen, M., Chartash, E., Sengupta, N., Grober, J., Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 32:5 (2005), 811–819.
63. Goligher, E.C., Pouchot, J., Brant, R., et al. Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus. J Rheumatol 35:4 (2008), 635–642.
64. Turner, D., Schünemann, H.J., Griffith, L.E., et al. The minimal detectable change cannot reliably replace the minimal important difference. J Clin Epidemiol 63:1 (2010), 28–36.
65. Goodwin, L.D., Leech, N.L., Understanding correlation: factors that affect the size of r. J Experiment Educ 74:3 (2006), 249–266.
66. Garrison, C., Cook, C., Clinimetrics corner: the Global Rating of Change Score (GRoC) poorly correlates with functional measures and is not temporally stable. J Man Manip Ther 20:4 (2012), 178–181.
67. Miravitlles, M., Ferrer, J., Baró, E., Lleonart, M., Galera, J., Differences between physician and patient in the perception of symptoms and their severity in COPD. Respir Med 107:12 (2013), 1977–1985.
68. Cella, D., Lai, J.S., Stone, A., Self-reported fatigue: one dimension or more? Lessons from the Functional Assessment of Chronic Illness Therapy—Fatigue (FACIT-F) questionnaire. Support Care Cancer 19:9 (2011), 1441–1450.
69. Criner, G.J., Bourbeau, J., Diekemper, R.L., et al. Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society guideline. Chest 147:4 (2015), 894–942.
70. Schünemann, H.J., Puhan, M., Goldstein, R., Jaeschke, R., Guyatt, G.H., Measurement properties and interpretability of the Chronic Respiratory Disease Questionnaire (CRQ). COPD 2:1 (2005), 81–89.
71. Alma, H., de Jong, C., Jelusic, D., et al. Baseline health status and setting impacted minimal clinically important differences in COPD: an explorative study. J Clin Epidemiol 116 (2019), 49–61.